Dr. Kim O'Connor, MD
Claim this profileInstitut universitaire de cardiologie et de pneumologie de Québec - Université Laval
Studies Tricuspid Regurgitation
Studies Tricuspid Valve Disease
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Kim O'Connor, MD is currently running
Transcatheter Valve Repair
for Mitral Regurgitation
This trial tests a new device called Edwards PASCAL that fixes leaky heart valves without surgery. It is for patients who can't have surgery or haven't improved with other treatments. The device helps the valve close better, stopping blood from leaking backward.
Recruiting1 award N/A9 criteria
Edwards PASCAL System
for Tricuspid Regurgitation
This trial tests a new device that fixes a leaky heart valve without surgery in patients who are too risky for traditional surgery. The device helps the valve close properly to stop blood from leaking backward. The first device specifically designed for this purpose is the paravalvular leak device (PLD - Occlutech).
Recruiting1 award N/A6 criteria
More about Kim O'Connor, MD
Clinical Trial Related7 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Kim O'Connor, MD has experience with
- Edwards PASCAL System
- Optimal Medical Therapy
- Abbott Mitraclip System
Breakdown of trials Kim O'Connor, MD has run
Tricuspid Regurgitation
Tricuspid Valve Disease
Tricuspid Valve Regurgitation
Mitral Regurgitation
Mitral Valve Disease
Other Doctors you might be interested in
Élisabeth Bédard, MDInstitut universitaire de cardiologie et de pneumologie de Québec - Université Laval
Francois Dagenais, MDInstitut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ)
Josep Rodés-Cabau, MDInstitut universitaire de cardiologie et de pneumologie de Québec - Université Laval
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kim O'Connor, MD specialize in?
Kim O'Connor, MD focuses on Tricuspid Regurgitation and Tricuspid Valve Disease. In particular, much of their work with Tricuspid Regurgitation has involved treating patients, or patients who are undergoing treatment.
Is Kim O'Connor, MD currently recruiting for clinical trials?
Yes, Kim O'Connor, MD is currently recruiting for 2 clinical trials in Québec Quebec. If you're interested in participating, you should apply.
Are there any treatments that Kim O'Connor, MD has studied deeply?
Yes, Kim O'Connor, MD has studied treatments such as Edwards PASCAL System, Optimal Medical Therapy, Abbott Mitraclip System.
What is the best way to schedule an appointment with Kim O'Connor, MD?
Apply for one of the trials that Kim O'Connor, MD is conducting.
What is the office address of Kim O'Connor, MD?
The office of Kim O'Connor, MD is located at: Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Québec, Quebec G1V 4G5 Canada. This is the address for their practice at the Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.